Psyence Biomedical (Psyence Biomedical) ROCE % : -422.87% (As of Mar. 2023)

View and export this data going back to 2024. Start your Free Trial

What is Psyence Biomedical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Psyence Biomedical's annualized ROCE % for the quarter that ended in Mar. 2023 was -422.87%.

Psyence Biomedical ROCE % Historical Data

The historical data trend for Psyence Biomedical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psyence Biomedical ROCE % Chart

Psyence Biomedical Annual Data

Trend

Mar21

Mar22

Mar23

ROCE %

-56.33

-422.87

Psyence Biomedical Semi-Annual Data
	Mar21	Mar22	Mar23
ROCE %	-	-56.33	-422.87

Psyence Biomedical ROCE % Calculation

Psyence Biomedical's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	-3.125	/	( ( (1.806 - 0.13)	+	(1.573 - 1.771) )	/ 2 )
	=	-3.125	/	( (1.676	+	-0.198)	/ 2 )
	=	-3.125	/	0.739
	=	-422.87 %

Psyence Biomedical's ROCE % of for the quarter that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2023 )		(Q: Mar. 2022 )		(Q: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2023 )		(Q: Mar. 2022 )		(Q: Mar. 2023 )
	=	-3.125	/	( ( (1.806 - 0.13)	+	(1.573 - 1.771) )	/ 2 )
	=	-3.125	/	( ( 1.676	+	-0.198 )	/ 2 )
	=	-3.125	/	0.739
	=	-422.87 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2023) EBIT data.

Psyence Biomedical (NAS:PBM) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Psyence Biomedical ROCE % Related Terms

Thank you for viewing the detailed overview of Psyence Biomedical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Psyence Biomedical (Psyence Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Psyence Biomedical Ltd (NAS:PBM) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

121 Richmond Street West, Penthouse Suite 1300, Toronto, ON, CAN, M5H 2K1

Website

https://www.psyence.com

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed ISO22000 facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

Psyence Biomedical (Psyence Biomedical) Headlines

From GuruFocus

Thinking about buying stock in Psyence Biomedical, Micron Technology, Conservative Broadcast Media Journalism, Qualcomm, or Cibus?

By PRNewswire • 02-12-2024